Zymeworks financials
$27.20+0.29%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.6M | $2.4M | $2.5M | $27.6M | $48.7M | $27.1M | $31.0M | $16.0M | $19.2M | $10.0M | $16.9M | $16.5M |
| Gross profit | $4.6M | $2.4M | $2.5M | $27.6M | $48.7M | $27.1M | $31.0M | $16.0M | $19.2M | $10.0M | $16.9M | $16.5M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$42.2M | -$47.1M | -$44.2M | -$22.1M | -$674.0K | -$25.6M | -$22.2M | -$34.2M | -$42.9M | -$37.8M | -$23.4M | -$33.2M |
| Net income | -$45.0M | -$44.2M | -$41.2M | -$19.6M | $2.3M | -$22.6M | -$23.5M | -$29.9M | -$37.7M | -$31.7M | -$14.5M | -$28.7M |
| Net margin | −980.8% | −1834.0% | −1638.5% | −71.0% | 4.8% | −83.5% | −75.8% | −186.6% | −195.8% | −315.6% | −85.6% | −173.8% |
| Diluted EPS | $-0.62 | $-0.59 | $-0.56 | $-0.26 | $0.03 | $-0.30 | $-0.31 | $-0.39 | $-0.49 | $-0.42 | $-0.20 | $-0.41 |
| EBITDA | -$41.0M | -$46.0M | -$43.1M | -$20.6M | $1.8M | -$23.0M | -$19.2M | -$32.2M | -$23.7M | -$36.0M | -$23.4M | -$30.2M |
| Operating cash flow | -$31.9M | -$45.7M | -$10.3M | -$31.4M | $12.1M | -$3.4M | -$41.5M | -$5.9M | -$25.0M | -$37.7M | $14.0M | -$42.7M |
| Free cash flow | -$31.9M | -$45.9M | -$10.8M | -$31.8M | $11.6M | -$3.4M | -$41.8M | -$6.8M | -$25.6M | -$37.9M | $13.6M | -$43.6M |
| Diluted shares | 73.0M | 74.7M | 73.3M | 75.8M | 77.4M | 75.2M | 74.7M | 76.2M | 76.4M | 76.2M | 70.8M | 70.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $179.4M | $244.3M | $41.2M | $64.8M | $98.3M | $76.2M |
| Short-term investments | $91.3M | $120.4M | $187.6M | $187.1M | $183.1M | $189.1M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $397.0M | $478.2M | $346.5M | $397.3M | $408.4M | $425.5M |
| Total liabilities | $316.6M | $314.6M | $78.0M | $77.2M | $73.9M | $100.6M |
| Shareholders' equity | $80.4M | $163.6M | $268.5M | $320.1M | $334.5M | $325.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology